Cone Health Heart and Vascular

[Cone Health Heart and Vascular @ConeHeartVasc]

It’s a new beginning at Cone Heart and Vascular Center with the the opening of the Stephen D Bell Family building. First patients today

[Cone Health Heart and Vascular @ConeHeartVasc]

Beginning a new era. Cone Health Heart and Vascular!

[Cone Health Heart and Vascular @ConeHeartVasc]

@SVRaoMD @HeartBobH So well deserved

[Cone Health Heart and Vascular @ConeHeartVasc]

Cone Health hypertension expert and Director of CV Prevention Tiffany Randolph discusses renal denervation https://t.co/5axFBI0dr7

[Cone Health Heart and Vascular @ConeHeartVasc]

https://t.co/9qQiYdvfsk

[Cone Health Heart and Vascular @ConeHeartVasc]

Builds on the early observations of ADAPT-DES

[Gregg W. Stone MD @GreggWStone]

Our publ in Lancet: IPD pooled analysis of all 6 RCTs in which 23,256 pts were treated with 1-yr DAPT vs. 2wks-3mos DAPT (median 78d) followed by ticagrelor monoRx. MACE favored short DAPT, and major bleeding and mortality were reduced. Similar results in CCS & ACS, even post-MI.

[Cone Health Heart and Vascular @ConeHeartVasc]

Coming soon to Cone HVC-April 2025

[Cone Health Heart and Vascular @ConeHeartVasc]

@LisaRoseJones1 Good luck Lisa

[Cone Health Heart and Vascular @ConeHeartVasc]

@SVRaoMD The best of the best, Dr Sunil Rao

[Cone Health Heart and Vascular @ConeHeartVasc]

Things are happening on the Moses Cone Campus with the new Heart and Vascular Ambulatory Center and additional cath labs #greensboro #NCCACC #Conehealth #Triadhealthnetwork

[Cone Health Heart and Vascular @ConeHeartVasc]

@DrChuckSimonton @BillONeillMD @NavinKapur4 @GreggWStone It was a great meeting, with a large contingent from our organization attending, led by our VP HVC Ruth Fisher

[Cone Health Heart and Vascular @ConeHeartVasc]

@CMichaelGibson Should be a great trial

[C. Michael Gibson MD @CMichaelGibson]

Thrombin (blood clotting) is elevated after a heart attack & is associated with worse outcomes. Inhibiting thrombin improved death, heart attack & stroke in 4 previous trials.
We are testing the hypothesis with factor xi inhibition to reduce bleeding in 16,000 pts at 1000 sites❤️

[Leslie L Davis, PhD, NP, FAAN @LLDavis_UNCCH]

@DrKTobb @ConeHeartVasc @ConeHealth @kcferdmd @kewatson @DrMarthaGulati @DocBanks84 @RBP0612 @ijeomaheartdoc @NMHheartdoc Is this star (Dr Tobb) on your radar for leading the way to improve health disparities for all. 🎤 drop after she ended her talk today!
@drktobb

[Cone Health Heart and Vascular @ConeHeartVasc]

Novel molecules that can ultimately be produced at low cost will transform CV risk. The LeBauer-Brodie Center will help drive the revolution
#Ionis #ACC #ConeHealth #Lipids

[Cone Health Heart and Vascular @ConeHeartVasc]

Dan Bensimhon discusses Heart Failure Devices at NCSCACC in Asheville.
#ConeHealth #NCCACC #HFSA #Heartfailure #Moonlighting

[Cone Health Heart and Vascular @ConeHeartVasc]

Dr Kardie Tobb discussing cardiovascular health equity at NCSC American College of Cardiology Annual Scientific Session at the Grove Park
#ACC #NCCACC #ConeHealth #healthequity #

[Cone Health Heart and Vascular @ConeHeartVasc]

Join us November 10 @TangerCenter for SHARE THE BEAT, the annual benefit in support of the Heart and Vascular Patient Care Fund. Fifty returns for a great evening of fun and entertainment.

[Recor Medical @RecorMedical]

NEWS: An update on the outcome of today’s FDA panel meeting on the Paradise Ultrasound Renal Denervation System PMA, our investigational device in the U.S. for treatment of hypertension: https://t.co/euBCo64Fqh

#RenalDenervation #Hypertension #uRDN

[Duke Clinical Research Institute @DCRINews]

In the U.S., two-thirds of patients with T2D will develop ASCVD. The DCRI-led COORDINATE-Diabetes trial shows how a multidisciplinary approach to treatment can “increase the prescriptions of the therapies proven effective for patients,” says @NPagidipati: https://t.co/7iNdwul3l0